These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 19367164)

  • 41. Dramatic recovery of vision in patient with acute central retinal artery occlusion treated with local intra-arterial tissue plasminogen activator.
    Margolin EA; Rai A; Goldfarb J; Zaslavsky K; Kohly R; Nicholson P
    BMJ Case Rep; 2020 Apr; 13(4):. PubMed ID: 32300037
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of intravenous tissue-type plasminogen activator in central retinal artery occlusion: report from a randomized, controlled trial.
    Chen CS; Lee AW; Campbell B; Lee T; Paine M; Fraser C; Grigg J; Markus R
    Stroke; 2011 Aug; 42(8):2229-34. PubMed ID: 21757667
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of the Effect of Superselective Ophthalmic Artery Thrombolysis for Central Retinal Artery Occlusion.
    Kang N; Xue Y; Wang F; Guan Q; Li M
    Ophthalmic Res; 2024; 67(1):387-392. PubMed ID: 38897178
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute Central Retinal Artery Occlusion Seen within 24 Hours at a Tertiary Institution.
    Chan W; Flowers AM; Meyer BI; Bruce BB; Newman NJ; Biousse V
    J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105988. PubMed ID: 34271275
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognosis of central retinal artery occlusion: local intraarterial fibrinolysis versus conservative treatment.
    Schmidt DP; Schulte-Mönting J; Schumacher M
    AJNR Am J Neuroradiol; 2002 Sep; 23(8):1301-7. PubMed ID: 12223369
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Idiopathic bilateral central artery occlusion in a young woman.
    Kinori M; Simon SS; Kurup SP; Mets-Halgrimson R; Jampol LM; Zeid JL
    J AAPOS; 2017 Oct; 21(5):418-420.e1. PubMed ID: 28844751
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evidence for an enduring ischaemic penumbra following central retinal artery occlusion, with implications for fibrinolytic therapy.
    McLeod D; Beatty S
    Prog Retin Eye Res; 2015 Nov; 49():82-119. PubMed ID: 26113210
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Selective thrombolysis for the treatment of the central retinal artery oclusion - a new challenge for a stand-by cardiac catheterisation laboratory].
    Lewandowski M; Gorący J; Modrzejewski A; Lubiński W; Jodko L; Kornacewicz-Jach Z
    Kardiol Pol; 2011; 69(1):101-3. PubMed ID: 21267984
    [No Abstract]   [Full Text] [Related]  

  • 49. Local intraarterial fibrinolysis administered in aliquots for the treatment of central retinal artery occlusion: the Johns Hopkins Hospital experience.
    Aldrich EM; Lee AW; Chen CS; Gottesman RF; Bahouth MN; Gailloud P; Murphy K; Wityk R; Miller NR
    Stroke; 2008 Jun; 39(6):1746-50. PubMed ID: 18420951
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Retrobulbar Spot Sign Predicts Thrombolytic Treatment Effects and Etiology in Central Retinal Artery Occlusion.
    Nedelmann M; Graef M; Weinand F; Wassill KH; Kaps M; Lorenz B; Tanislav C
    Stroke; 2015 Aug; 46(8):2322-4. PubMed ID: 26111890
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatments for Acute Nonarteritic Central Retinal Artery Occlusion: Findings From a Cochrane Systematic Review.
    Lin JC; Song SL; Ng SM; Scott IU; Greenberg PB
    Ophthalmic Surg Lasers Imaging Retina; 2023 Nov; 54(11):650-653. PubMed ID: 37855834
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thrombolytic therapy with alteplase for ischaemic stroke.
    Drug Ther Bull; 2009 Feb; 47(2):14-8. PubMed ID: 19193701
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Central retinal artery occlusion-A new, provisional treatment approach.
    Chronopoulos A; Schutz JS
    Surv Ophthalmol; 2019; 64(4):443-451. PubMed ID: 30707925
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Current treatment of central retinal artery occlusion: a national survey.
    Youn TS; Lavin P; Patrylo M; Schindler J; Kirshner H; Greer DM; Schrag M
    J Neurol; 2018 Feb; 265(2):330-335. PubMed ID: 29236169
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Use of thrombolytic agents during invasive treatments for retinal vascular occlusions].
    Sosnovskiĭ VV; Sdobnikova SV
    Vestn Oftalmol; 2007; 123(5):51-4. PubMed ID: 18078061
    [No Abstract]   [Full Text] [Related]  

  • 56. INTRAVENOUS THROMBOLYTIC THERAPY FOR ACUTE NONARTERITIC CENTRAL RETINAL ARTERY OCCLUSION. A REVIEW.
    Janská K; Bodnár R; Janský P; Vosko M
    Cesk Slov Oftalmol; 2022; 2(Ahead of Print):1001-1009. PubMed ID: 35105148
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vitreous and retinal amino acid concentrations in experimental central retinal artery occlusion in the primate.
    Kwon YH; Rickman DW; Baruah S; Zimmerman MB; Kim CS; Boldt HC; Russell SR; Hayreh SS
    Eye (Lond); 2005 Apr; 19(4):455-63. PubMed ID: 15184939
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Central retinal artery occlusion: timing and mode of presentation.
    Rudkin AK; Lee AW; Chen CS
    Eur J Neurol; 2009 Jun; 16(6):674-7. PubMed ID: 19374663
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A review of central retinal artery occlusion: clinical presentation and management.
    Varma DD; Cugati S; Lee AW; Chen CS
    Eye (Lond); 2013 Jun; 27(6):688-97. PubMed ID: 23470793
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Central retinal artery occlusion. Importance of selective intra-arterial fibrinolysis].
    Framme C; Spiegel D; Roider J; Sachs HG; Lohmann CP; Butz B; Link J; Gabel VP
    Ophthalmologe; 2001 Aug; 98(8):725-30. PubMed ID: 11552411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.